179 related articles for article (PubMed ID: 19540426)
1. Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.
Kheterpal I; Kastin AJ; Mollah S; Yu C; Hsuchou H; Pan W
Peptides; 2009 Jul; 30(7):1276-81. PubMed ID: 19540426
[TBL] [Abstract][Full Text] [Related]
2. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
Zadina JE; Kastin AJ; Krieg EF; Coy DH
Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
Kastin AJ; Hahn K; Banks WA; Zadina JE
Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
[TBL] [Abstract][Full Text] [Related]
4. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
[TBL] [Abstract][Full Text] [Related]
5. Degradation of melanotropin inhibiting factor by brain.
Hui KS; Cheng KP; Wong KH; Salschutz M; Lajtha A
J Neurochem; 1980 Aug; 35(2):471-8. PubMed ID: 6108995
[TBL] [Abstract][Full Text] [Related]
6. Carrier-mediated transport of labeled oxytocin from brain to blood.
Durham DA; Banks WA; Kastin AJ
Neuroendocrinology; 1991 May; 53(5):447-52. PubMed ID: 1678495
[TBL] [Abstract][Full Text] [Related]
7. Regional differences in peptide degradation by rat cerebral microvessels: a potential novel regulatory mechanism for communication between blood and brain.
Kastin AJ; Hahn K; Zadina JE
Life Sci; 2001 Aug; 69(11):1305-12. PubMed ID: 11521754
[TBL] [Abstract][Full Text] [Related]
8. Separation of alkylaminonaphthylenesulfonyl peptides and amin acids by high-performance liquid chromatography. Methods for measuring melanotropin inhibiting factor breakdown.
Hui KS; Salschutz M; Davis BA; Lajtha A
J Chromatogr; 1980 May; 192(2):341-50. PubMed ID: 6104674
[TBL] [Abstract][Full Text] [Related]
9. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2).
Hackler L; Kastin AJ; Zadina JE
Peptides; 1994; 15(6):945-50. PubMed ID: 7991457
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
Erchegyi J; Kastin AJ; Zadina JE
Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
[TBL] [Abstract][Full Text] [Related]
11. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
Manberg PJ; Youngblood WW; Kizer JS
Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
[TBL] [Abstract][Full Text] [Related]
12. Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex.
Horvath A; Kastin AJ
Int J Pept Protein Res; 1990 Sep; 36(3):281-4. PubMed ID: 1980671
[TBL] [Abstract][Full Text] [Related]
13. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
14. Isolation of Tyr-W-MIF-1 from bovine hypothalami.
Hackler L; Kastin AJ; Erchegyi J; Zadina JE
Neuropeptides; 1993 Mar; 24(3):159-64. PubMed ID: 8097302
[TBL] [Abstract][Full Text] [Related]
15. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
Banks WA; Kastin AJ; Ehrensing CA
J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
[TBL] [Abstract][Full Text] [Related]
16. Binding of Tyr-MIF-1 to isolated brain capillaries.
Pretorius HT; Kastin AJ; Banks WA
Brain Res Bull; 1986 Dec; 17(6):829-31. PubMed ID: 2879616
[TBL] [Abstract][Full Text] [Related]
17. Alpha-MSH and MIF-2 effects on serotonin levels and accumulation in various rat brain areas.
Spirtes MA; Kostrzewa RM; Kastin AJ
Pharmacol Biochem Behav; 1975; 3(6):1011-5. PubMed ID: 4814
[TBL] [Abstract][Full Text] [Related]
18. Degradation of prolylleucylglycinamide (MIF) by mouse brain.
Neidle A; Yessaian N; Lajtha A
Neurochem Res; 1980 Sep; 5(9):1011-23. PubMed ID: 6111031
[TBL] [Abstract][Full Text] [Related]
19. Tyr-MIF-1 binding in brain is not altered by ligands selective for the GABAA/benzodiazepine receptor.
Zadina JE; Kastin AJ; Ge LJ
Neurosci Lett; 1990 Mar; 110(1-2):143-7. PubMed ID: 1970141
[TBL] [Abstract][Full Text] [Related]
20. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
